Chemoprophylaxis and the epidemiological characteristics of re-emergent P. vivax malaria in the Republic of Korea

Bulletin of the World Health Organization

Volumn 84, Issue 10, 2006, Pages 827-834

  Kim, Changsoo ^a   Dong, Chun Shin ^a   Tai, Soon Yong ^a   Dae, Kyu Oh ^b   Rock, Kwon Kim ^c   Park, Keeho ^b   Suh, Il ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

^c Korean Armed Forces Medical Command   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; HYDROXYCHLOROQUINE; PRIMAQUINE;

ANTIBIOTIC RESISTANCE; DISEASE TREATMENT; EPIDEMIOLOGY; HEALTH RISK; MALARIA;

ARTICLE; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC TEST; DRUG DOSE REGIMEN; HUMAN; INFECTION RISK; KOREA; MAJOR CLINICAL STUDY; MALARIA; PLASMODIUM VIVAX; PREVALENCE;

ANIMALS; ANTIMALARIALS; CHEMOPREVENTION; CLOTHING; DRUG RESISTANCE; EPISODE OF CARE; HUMANS; HYDROXYCHLOROQUINE; INSECTICIDES; KOREA; MALARIA, VIVAX; MILITARY MEDICINE; MILITARY PERSONNEL; OCCUPATIONAL EXPOSURE; PERMETHRIN; PLASMODIUM VIVAX; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS;

ASIA; EURASIA; FAR EAST; KOREA; SOUTH KOREA;

PLASMODIUM VIVAX;

EID: 33750263815     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.05.029546     Document Type: Article

References (33)

1. World Health Organization. Synopsis of the world malaria situation, 1979. Wkly Epidemiol Rec 1981;56:145-9.
2. Chai IH, Lim GI, Yoon SN, Oh WI, Kim SJ, Chai JY. Occurrence of tertian malaria in a male patient who has never been abroad. [In Korean.]. Korean J Parasitol 1994;32:195-200.
3. Lee JS, Lee WJ, Cho SH, Ree HI. Outbreak of vivax malaria in areas adjacent to the demilitarized zone, South Korea, 1998. Am J Trop Med Hyg 2002;66:13-7.
4. Park JW, Klein TA, Lee HC, Pacha LA, Ryu SH, Yeom JS, et al. Vivax malaria: a continuing health threat to the Republic of Korea. Am J Trop Med Hyg 2003;69:159-67.
5. Korea Center for Disease Control and Prevention. Epidemiology of malaria in Korea, 2003. CDMR 2004;15:85-91.
6. Seidlein L, Greenwood B. Mass administrations of antimalarial drugs. Trends Parasitol 2003;19:452-60.
7. Greenwood B. The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas. Am J Trop Med Hyg 2004;70:1-7.
8. Park K, Kang JK. Effectiveness of primaquine terminal prophylaxis against late primary attacks of P. vivax malaria: a case-control study among troops of the Republic of Korea Army. Trans R Soc Trop Med Hyg 2003;97:441-2.
9. Yeom JS, Ryu SH, Oh S, Choi DH, Song KJ, Oh YH, et al. Evaluation of antimalarial effects of mass chemoprophylaxis in the Republic of Korea army. J Korean Med Sci 2005;20:707-12.
10. Gilles HM, Warrell DA. Bruce-Chwatt's essential malariology. Third Edition. Boston: Edward Arnold Press; 1993. p. 127-31.
11. Schwartz E, Parise M, Kozarsky P, Cetron M. Delayed onset of malaria - implications for chemoprophylaxis in travelers. N Engl J Med 2003;349:1510-6.
12. Kim HC, Lee KW, Miller WB, Strickman D. Seasonal prevalence of mosquitoes collected from light traps in Korea (1997-1998). Korean J Entomol 2001;31:7-13.
13. Cogswell FB. The hypnozoite and relapse in primate malaria. Clin Microbiol Rev 1992;5:26-35.
14. Shute PG, Lupascu G, Branzei P, Maryon M, Constantinescu P, Bruce-Chwatt LJ, et al. A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the length of the prepatent period. Trans R Soc Trop Med Hyg 1977;70:474-81.
15. Tiburskaja NA, Vrublevskaja OS. The course of infection caused by the North Korean strain of vivax malaria. Geneva: World Health Organization; 1977. WHO document WHO/MAL/77.895.
16. Oh MD, Shin H, Shin D, Kim U, Lee S, Kim N, et al. Clinical features of vivax malaria. Am J Trop Med Hyg 2001;65:143-6.
17. Kho WG, Park YH, Chung JY, Kim JP, Hong ST, Lee WJ, et al. Two new genotypes of Plasmodium vivax circumsporozoite protein found in the Republic of Korea. Korean J Parasitol 1999;37:265-70.
18. Han ET, Park JH, Shin EH, Choi MH, Oh MD, Chai JY. Apical membrane antigen-1 (AMA-1) gene sequences of re-emerging Plasmodium vivax in South Korea. Korean J Parasitol 2002;40:157-62.
19. Lim CS, Kim SH, Kwon SI, Song JW, Song KJ, Lee KN. Analysis of Plasmodium vivax merozoite surface protein-1 gene sequences from resurgent Korean isolates. Am J Trop Med Hyg 2000;62:261-5.
20. Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis 2004;39:1336-45.
21. Rajgor DD, Gogtay NJ, Kadam VS, Kamtekar KD, Dalvi SS, Chogle AR, et al. Efficacy of a 14-day primaquine regimen in preventing relapses in patients with Plasmodium vivax malaria in Mumbai, India. Trans R Soc Trop Med Hyg 2003;97:438-40.
22. Looareesuwan S, Buchachart K, Wilairatana P, Chalermrut K, Rattanapong Y, Amradee S, et al. Primaquine-tolerant vivax malaria in Thailand. Ann Trop Med Parasitol 1997;91:939-43.
23. Baird JK, Fryauff DJ, Hoffman SL. Primaquine for prevention of malaria in travelers. Clin Infect Dis 2003;37:1659-67.
24. Yi KJ, Chung MH, Kim HS, Kim CS, Pai SH. A relapsed case of imported tertian malaria after a standard course of hydroxychloroquine and primaquine therapy. Korean J Parasitol 1998;36:143-6.
25. Barid JK. Rieckmann. Can primaquine therapy for vivax malaria be improved? Trends Parasitol 2003;19:115-20.
26. Brueckner RD, Lasseter KC, Lim ET, Schuster BG. First-time-in humans safety and pharmacokinetics of WR238605, a new antimalarial. Am J Trop Med Hyg 1998;58:645-9.
27. Lell B, Faucher JF, Missinou MA, et al. Malaria chemoprophylaxis with tafenoquine: a randomized study. Lancet 2000;355:2041-5.
28. Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP. An outbreak of malaria in US army rangers returning from Afghanistan. JAMA 2005;293:212-6.
29. Hung le Q, Vries PJ, Giao PT, Nam NV, Binh TQ, Chong MT, et al. Control of malaria: a successful experience from Viet Nam. Bull World Health Organ 2002;80:660-6.
30. Chai JY. Re-emerging Plasmodium vivax malaria in the Republic of Korea. Korean J Parasitol 1999;37:129-43.
31. Kho WK, Jang JY, Hong ST, Lee HW, Lee WJ, Lee JS. Border malaria characters of reemerging vivax malaria in the Republic of Korea. Korean J Parasitol 1999;37:71-6.
32. Yeom JS, Ryu SH, Oh S, Lee WJ, Kim TS, Kim KH, et al. Status of Plasmodium vivax malaria in the Republic of Korea during 2001-2003. Am J Trop Med Hyg 2005;73:604-8.
33. Korea Center for Disease Control and Prevention. Support for malaria control in North Korea. CDMR 2005;16:108.